Skip to main content
. 2021 Apr 29;16(4):e0248937. doi: 10.1371/journal.pone.0248937

Table 1. The demographic, clinical and laboratory characteristics of the studied groups.

Demographic, Clinical and Laboratory Characteristics Patients with active GD Patients in normalized thyroid hormone levels Controls
(n = 35) (n = 35) (n = 40)
Demographic and Clinical Data
Age at presentation; yrs 9–18 (11.45 ± 1.50) - 8–18 (12.54 ± 1.62)
P1-value 0.323 -
Gender
Girls 25 (71.43%) 25 (71.43%) 20 (50%)
Boys 10 (28.57%) 10 (28.57%) 20 (50%)
Heart rate; beats/minute 90–130 (110.00 ± 3.00) 80–100 (90.00 ± 5.00) 75–105 (85.00 ± 5.00)
P1-value 0.03 0.325
P2-value 0.01
Systolic blood pressure; mmHg 100–130 (110.00 ± 5.00) 90–110 (100.00 ± 0.00) 95–110 (100.00 ± 5.00)
P1-value 0.211 1.003
P2-value 0.212
Diastolic blood pressure; mmHg 60–80 (70.00 ± 0.00) 60–75 (65.00 ± 5.00) 55–80 (65.00 ± 0.00)
P1-value 0.456 1.002
P2-value 0.864
Body Mass Index; kg/m2 16–25 (18.90 ± 4.30) 18.5–26.9 (22.50 ± 2.30) 18.5–28.9 (24.9 ± 2.30)
P1-value 0.135 0.426
P2-value
Laboratory Data
TSH; μU/l 0.005–0.22 (0.01 ± 0.006) 0.37–3.55 (1.32 ± 0.45) 0.62–4.42 (1.75 ± 0.86)
P1-value 0.0001 0.345
P2-value 0.0001
fT4; pmol/l 24.30–46.52(32.10 ± 2.68) 7.25–16.33 (12.86 ± 1.36) 7.54–14.96 (11.46 ± 1.45)
P1-value 0.520
P2-value 0.0001 0.0001
fT3; pmol/l 15.45–29.68 (19.45 ± 2.70) 4.60–9.2 (5.50 ± 0.80) 3.80–7.80 (5.26 ± 1.06)
P1-value 0.866
P2-value 0.0001 0.0001
TRAb; IU/ml 180.60–470.37 (265.74 ± 55.86) 22.65–80.40 (42.36 ± 8.55) 16.88–64.25 (46.45 ± 6.60)
P1-value 0.688
P2-value 0.0001 0.0001
Intelligence Quotient (IQ)
Verbal IQ 80–130 (100.90 ± 10.28) 80–140 (102.70 ± 15.60) 90–145 (112.60 ± 18.55)
P1-value 0.345 0.433
P2-value 0.864
Performance IQ 70–135 (98.14 ± 12.33) 70–145 (99.19 ± 13.58) 86–132 (108.87 ± 15.60)
P1-value 0.235 0.268
P2-value 0.824
Full scale IQ 70–135 (101.18 ± 15.31) 75–137 (100.06 ± 12.52) 80–133 (105.90 ± 9.93)
P1-value 0.632 0.636
P2-value 1.022

Data are expressed as mean ± SD; number (%).

P1: significance versus controls; P2: significance versus those with active GD.

TSH: thyroid stimulating hormone; fT4: free thyroxine; fT3: free triiodothyronine; TRAbs, thyroid-stimulating hormone receptor antibodies.